title: Indeterminate western blot patterns in a cohort of individuals at high risk for human immunodeficiency virus (HIV-1) exposure.
abstract: Our objective was to map serial patterns of Western blot reactivity over time of a cohort of initially ELISA-negative, Western blot-indeterminate individuals from a high-risk group and to determine if these individuals were at increased risk of harboring occult HIV-1 infection. A 2-year prospective study used serial ELISA, two types of Western blot, immunologic profiles, HIV-1 culture, and analysis by polymerase chain reaction. Subjects were 20 ELISA-negative, Western blot indeterminate homosexual volunteers and 20 matched seronegative controls. Results showed that 19 of 20 study subjects completed a mean of 17.0 months of clinical and laboratory follow-up. Reactivities with p24 and/or with p55 were the two most commonly observed Western blot patterns, occurring in 70% of individuals. Specific Western blot reactivity was dependent upon the particular immunoblot preparation being used and varied considerably on a longitudinal basis. No individual pattern appeared predictive of an increased likelihood of subsequent seroconversion to HIV-1 relative to controls. By all other criteria including polymerase chain reaction analysis, samples from 17 of 19 individuals remained negative for HIV-1 at each time point. Two individuals evolved from an indeterminate to a positive Western blot and, simultaneously, from a negative to a positive polymerase chain reaction analysis, during follow-up. Our conclusions were as follows. ELISA-negative, Western blot-indeterminate individuals from a high-risk group show marked variability in immunoblot findings over time, and these patterns do not appear predictive of an increased likelihood of infection.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Clinical and Molecular Retrovirology Section, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland 20892.
authors.forename: R T
authors.initials: RT
authors.lastname: Davey
authors.forename: L R
authors.initials: LR
authors.lastname: Deyton
authors.forename: J A
authors.initials: JA
authors.lastname: Metcalf
authors.forename: M
authors.initials: M
authors.lastname: Easter
authors.forename: J A
authors.initials: JA
authors.lastname: Kovacs
authors.forename: M
authors.initials: M
authors.lastname: Vasudevachari
authors.forename: M
authors.initials: M
authors.lastname: Psallidopoulos
authors.forename: L M
authors.initials: LM
authors.lastname: Thompson
authors.forename: J
authors.initials: J
authors.lastname: Falloon
authors.forename: M A
authors.initials: MA
authors.lastname: Polis
mesh_terms: D000293:Adolescent; D000328:Adult; D015153:Blotting, Western; D015331:Cohort Studies; D015488:HIV Antigens / Q000032:analysis; D015658:HIV Infections / Q000175:diagnosis* / Q000276:immunology; D006679:HIV Seropositivity / Q000175:diagnosis / Q000276:immunology; D015497:HIV-1 / Q000276:immunology; D006801:Humans; D008297:Male; D008875:Middle Aged; D016133:Polymerase Chain Reaction; D011446:Prospective Studies; D012307:Risk Factors; D014759:Viral Envelope Proteins / Q000032:analysis
chemical_list: D015488:HIV Antigens; D014759:Viral Envelope Proteins